Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Allegiant Travel Company (NASDAQ: ALGT) shares gained 6.85 percent to close at $108.59 a share Thursday. The stock traded between $104.28 and $109.39 on volume of 185,080 million shares traded. Analysts at Raymond James have recently upgraded the company’s rating to “outperform” from “market perform”. Shares of Allegiant Travel have gained approximately 3.0 percent year-to-date.
Find out more about Allegiant Travel including full access to the free equity report at:
www.RDInvesting.com/ALGT
Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares declined 3.59 percent to close at $2.42 a share Thursday. The stock traded between $2.40 and $2.56 on volume of 216,430 shares traded. Analysts at Leerink Swann have recently raised their price target on the company to $3.00 from $2.50. Shares of Amicus Therapeutics have gained approximately 3.0 percent year-to-date.
Find out more about Amicus Therapeutics including full access to the free equity report at:
www.RDInvesting.com/FOLD
H&E Equipment Services, Inc. (NASDAQ: HEES) shares gained 6.05 percent to close at $38.22 a share Thursday. The stock traded between $36.76 and $38.50 on volume of 213,022 shares traded. Analysts at UBS have recently upgraded the company’s rating to “buy” from “neutral”. Shares of H&E Equipment Services have gained approximately 28.0 percent year-to-date.
Find out more about H&E Equipment Services including full access to the free equity report at:
www.RDInvesting.com/HEES
Inphi Corporation (NYSE: IPHI) shares increased 7.51 percent to close at $15.17 a share Thursday. The stock traded between $14.51 and $15.22 on volume of 583,347 shares traded. Analysts at Jeffries UBS have recently upgraded the company’s rating to “buy” from “hold” and also raised its price target to $17.00. Shares of Inphi have gained approximately 18.0 percent year-to-date.
Find out more about Inphi including full access to the free equity report at:
www.RDInvesting.com/IPHI
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]